PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 184 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 1.20 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $206,622,000 | -31.0% | 3,900 | 0.0% | 0.04% | -25.5% |
| Q4 2015 | $299,481,000 | -81.9% | 3,900 | -90.3% | 0.05% | -76.5% |
| Q3 2015 | $1,652,220,000 | -42.2% | 40,200 | -0.5% | 0.22% | -31.8% |
| Q2 2015 | $2,857,088,000 | -20.4% | 40,400 | 0.0% | 0.32% | -20.3% |
| Q1 2015 | $3,589,540,000 | +14.0% | 40,400 | +13.8% | 0.40% | -2.0% |
| Q4 2014 | $3,147,430,000 | -8.8% | 35,500 | -0.3% | 0.41% | -15.7% |
| Q3 2014 | $3,450,352,000 | – | 35,600 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 550,000 | $18,442,000 | 6.98% |
| Gagnon Advisors, LLC | 193,860 | $6,500,000 | 6.06% |
| GAGNON SECURITIES LLC | 407,159 | $13,652,000 | 4.64% |
| Spyglass Capital Management LLC | 1,190,537 | $39,919,000 | 4.51% |
| Paulson & Co. | 1,716,727 | $57,562,000 | 2.20% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,627,521 | $54,571,000 | 1.73% |
| Elk Creek Partners, LLC | 265,146 | $8,890,000 | 1.53% |
| HealthCor Management, L.P. | 887,370 | $29,754,000 | 1.27% |
| Rock Springs Capital Management LP | 900,000 | $30,177,000 | 1.25% |
| Lisanti Capital Growth, LLC | 108,679 | $3,644,000 | 1.20% |